ARCHIVES

Caution Advised for Hormone Replacement Therapy

This article is from The Cancer Letter archive.

Vol. 12 No. 12 | March 21, 1986

Download PDF Visit The Full Archive

Related Articles

Skipper’s Impact: Drugs Curing 40,000 a Year

March 27, 1981

High Dose Chemotherapy Significantly Prolongs Survival In ECOG Clinical Trial

November 28, 2008

Prevention Trials Should Get More Funding, Coltman Says.

May 18, 2001

Phase III Xtandi Trial Meets Primary Endpoints Of Progression-Free and Overall Survival

November 29, 2013

Health Care Reform: Fundamental changes Ahead For Cancer Research And Care

October 8, 1993

Chabner Says Vials DCT Obtained From Burton Operation Were Contaminated

June 8, 1984